Aquestive Therapeutics(AQST)
$3.57-0.01 (-0.28%)
AQST
Aquestive Therapeutics financials statements
$3.57
At close:-0.01 (-0.28%)
Want to see AQST full AI Analyst Report?
Aquestive Therapeutics (AQST) Income Statement
2,493 Followers
Aquestive Therapeutics Income Statement
Last quarter (Q3 2026), Aquestive Therapeutics's total revenue was $7.56M, a decrease of 40.99% from the same quarter last year. In Q3, Aquestive Therapeutics's net income was $-16.50M. See Aquestive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 44.55M | $ 57.56M | $ 50.58M | $ 47.68M | $ 50.83M | |
| $ 27.39M | $ 39.69M | $ 29.75M | $ 28.29M | $ 35.84M | |
| $ 97.04M | $ 70.46M | $ 44.85M | $ 70.36M | $ 70.52M | |
| Depreciation and Amortization | $ 548.00K | $ 718.00K | $ 1.34M | $ 2.39M | $ 2.96M |
| $ -66.14M | $ -26.62M | $ 1.18M | $ -39.58M | $ -45.11M | |
| $ -69.65M | $ -30.77M | $ -15.10M | $ -42.07M | $ -34.68M | |
| $ -14.13M | $ -13.38M | $ 7.48M | $ -12.34M | $ -35.86M | |
| $ -83.78M | $ -44.15M | $ -7.63M | $ -54.41M | $ -70.54M | |
| $ -83.78M | $ -44.14M | $ -7.87M | $ -54.41M | $ -70.54M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.76 | $ -0.51 | $ -0.13 | $ -1.12 | $ -1.85 |
| Diluted EPS | $ -0.76 | $ -0.51 | $ -0.13 | $ -1.12 | $ -1.85 |
| Weighted Average Shares Outstanding | 121.97M | 86.73M | 61.26M | 48.73M | 38.08M |
| Weighted Average Shares Outstanding (Diluted) | 121.97M | 86.73M | 61.26M | 48.73M | 38.08M |
Currency in USD
